These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3550447)

  • 21. Comparative studies on the lethal, mutagenic, and recombinogenic effects of ultraviolet -A, -B, -C, and visible light with and without 8-methoxypsoralen in Saccharomyces cerevisiae.
    Mondon P; Shahin MM
    Photochem Photobiol; 1992 May; 55(5):713-21. PubMed ID: 1528985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic effect of 3-carbethoxypsoralen, angelicin, psoralen and 8-methoxypsoralen plus 365-nm irradiation in Saccharomyces cerevisiae: induction of reversions, mitotic crossing-over, gene conversion and cytoplasmic "petite" mutations.
    Averbeck D; Moustacchi E
    Mutat Res; 1979 Oct; 68(2):133-48. PubMed ID: 390387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutagenic and recombinogenic consequences of DNA-repair inhibition during treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea in Saccharomyces cerevisiae.
    Ferguson LR
    Mutat Res; 1990 Aug; 241(4):369-77. PubMed ID: 2198466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotoxicity of nitrosated ranitidine.
    Franekić J; Skupnjak S; Matijasević Z
    Mutat Res; 1989 Sep; 227(1):13-6. PubMed ID: 2671717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic activity in Saccharomyces cerevisiae and thin-layer chromatographic comparisons of medical grades of pyrvinium pamoate and monopyrvinium salts.
    Mehta RD; Hennig UG; von Borstel RC; Chatten LG
    Mutat Res; 1982; 102(1):59-69. PubMed ID: 6750373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testing of chemicals for genetic activity with Saccharomyces cerevisiae: a report of the U.S. Environmental Protection Agency Gene-Tox Program.
    Zimmermann FK; von Borstel RC; von Halle ES; Parry JM; Siebert D; Zetterberg G; Barale R; Loprieno N
    Mutat Res; 1984 May; 133(3):199-244. PubMed ID: 6374444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotoxicity of aflatoxin B1: evidence for a recombination-mediated mechanism in Saccharomyces cerevisiae.
    Sengstag C; Weibel B; Fasullo M
    Cancer Res; 1996 Dec; 56(23):5457-65. PubMed ID: 8968101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic effects of fresh cigarette smoke in Saccharomyces cerevisiae.
    Gairola C
    Mutat Res; 1982 Sep; 102(2):123-36. PubMed ID: 6755230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Petite' mutagenesis by anticancer drugs in Saccharomyces cerevisiae.
    Ferguson LR; Turner PM
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):591-6. PubMed ID: 3289944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the genetic activity of pyrvinium pamoate with that of several other anthelmintic drugs in Saccharomyces cerevisiae.
    Hennig UG; Galindo-Prince OC; Cortinas de Nava C; Savage EA; von Borstel RC
    Mutat Res; 1987 Feb; 187(2):79-89. PubMed ID: 3543669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of tumor promoters on ultraviolet light-induced mutation and mitotic recombination in Saccharomyces cerevisiae.
    Kunz BA; Hannan MA; Haynes RH
    Cancer Res; 1980 Jul; 40(7):2323-9. PubMed ID: 6992984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbial mutagenic effects of the DNA minor groove binder pibenzimol (Hoechst 33258) and a series of mustard analogues.
    Ferguson LR; Denny WA
    Mutat Res; 1995 Jun; 329(1):19-27. PubMed ID: 7539521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitotic crossing-over by anticancer drugs in Saccharomyces cerevisiae strain D5.
    Ferguson LR; Turner PM
    Mutat Res; 1988 Feb; 204(2):239-49. PubMed ID: 3278216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiation of the mutagenicity and recombinagenicity of bleomycin in yeast by unconventional intercalating agents.
    Hoffmann GR; Laterza AM; Sylvia KE; Tartaglione JP
    Environ Mol Mutagen; 2011 Mar; 52(2):130-44. PubMed ID: 20839230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutagenicity of constituents of pulp and paper mill effluent in growing cells of Saccharomyces cerevisiae.
    Nestmann ER; Lee EG
    Mutat Res; 1983 Mar; 119(3):273-80. PubMed ID: 6338377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutagenic activity of nitracrine derivatives in Salmonella typhimurium: relationship to drug physicochemical parameters, and to bacterial uvrB and recA genes and plasmid pKM101.
    Ferguson LR; Denny WA; O'Rourke SM
    Mutat Res; 1989 May; 223(1):13-22. PubMed ID: 2654627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutagenesis by the anti-tumour drug nitracrine in Escherichia coli.
    MacPhee DG; Liaskou D
    Mutat Res; 1989 Dec; 227(4):251-5. PubMed ID: 2685595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic effects of vinylcyclohexene diepoxide in yeast.
    Bronzetti G; Bauer C; Corsi C; Leporini C; Nieri R
    Boll Soc Ital Biol Sper; 1980 Sep; 56(18):1803-6. PubMed ID: 7016138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenic and recombinogenic activities of the food additive furylfuramide in eurkaryotes.
    Ong TM; Shahin MM
    Science; 1974 Jun; 184(4141):1086-7. PubMed ID: 4283384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bleomycin-induced mutation and recombination in Saccharomyces cerevisiae.
    Moore CW
    Mutat Res; 1978 Sep; 58(1):41-9. PubMed ID: 82205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.